JNJ
Johnson & Johnson
NYQ
$222.89
-0.62
(-0.28%)
Pullback · -1.26σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$536.5B
P/E ttm
25.8
Fwd P/E
17.5
Beta
0.26
Day range
$222.89
52w range
$199.91 – $251.71
Avg vol
7.7M
RSI(2)
4.2
ROE
26.4%
Net mgn
21.8%
FCF mgn
13.0%
Debt/Eq
0.68
Div yld
240.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-07-15
Matrix setup grades
Long
C
score 26 · tech 26 / 80 · support 0 / 20
KC1 lower, -1.24 ATR from EMA21 · doji
- · KC1 lower stretch — light dip
- · Doji — indecision, watch for reversal
- · Aligned with weak uptrend
Short
—
score 15 · tech 15 / 80 · support 0 / 20
below KC1 upper, -1.24 ATR from EMA21 · doji
- · Doji — indecision, watch for reversal
Options · swing
See more →
CALL
$230
2026-07-17
$5.08
PUT
$220
2026-07-17
$5.85
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-14
- EPS (act / est)
- 2.70 / 2.68
- Surprise
- +0.8%
- Next report
- 2026-07-15
About
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension,…